Project
Illumina Body Map 2
Navigation
Downloads
Results for YY1_YY2
Z-value: 1.78
Motif logo
Transcription factors associated with YY1_YY2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
YY1
|
ENSG00000100811.6 | YY1 transcription factor |
|
YY2
|
ENSG00000230797.2 | YY2 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| YY1 | hg19_v2_chr14_+_100705322_100705360 | -0.42 | 1.8e-02 | Click! |
| YY2 | hg19_v2_chrX_+_21874105_21874105 | -0.37 | 3.6e-02 | Click! |
Activity profile of YY1_YY2 motif
Sorted Z-values of YY1_YY2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr8_+_120885949 | 4.49 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chr3_-_149688896 | 4.40 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
| chr17_-_1303462 | 4.06 |
ENST00000573026.1
ENST00000575977.1 ENST00000571732.1 ENST00000264335.8 |
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
| chr19_-_46000251 | 3.99 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
| chr20_-_62129163 | 3.92 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr3_-_149688502 | 3.83 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
| chr3_-_149688655 | 3.74 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
| chr6_+_31588478 | 3.50 |
ENST00000376007.4
ENST00000376033.2 |
PRRC2A
|
proline-rich coiled-coil 2A |
| chr9_-_97356075 | 3.43 |
ENST00000375337.3
|
FBP2
|
fructose-1,6-bisphosphatase 2 |
| chr17_-_62050278 | 3.41 |
ENST00000578147.1
ENST00000435607.1 |
SCN4A
|
sodium channel, voltage-gated, type IV, alpha subunit |
| chr19_+_4791722 | 3.33 |
ENST00000269856.3
|
FEM1A
|
fem-1 homolog a (C. elegans) |
| chr9_-_35689900 | 3.27 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
TPM2
|
tropomyosin 2 (beta) |
| chr5_-_149669192 | 3.21 |
ENST00000398376.3
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr7_-_73038867 | 3.18 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
| chr7_-_73038822 | 3.16 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr7_+_123295861 | 3.12 |
ENST00000458573.2
ENST00000456238.2 |
LMOD2
|
leiomodin 2 (cardiac) |
| chr4_-_8073554 | 3.06 |
ENST00000510277.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr10_-_75385711 | 2.98 |
ENST00000433394.1
|
USP54
|
ubiquitin specific peptidase 54 |
| chr7_-_82073031 | 2.92 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr7_-_82073109 | 2.79 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr14_-_27066636 | 2.71 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
| chr19_-_39322299 | 2.68 |
ENST00000601094.1
ENST00000595567.1 ENST00000602115.1 ENST00000601778.1 ENST00000597205.1 ENST00000595470.1 |
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr19_-_13044494 | 2.64 |
ENST00000593021.1
ENST00000587981.1 ENST00000423140.2 ENST00000314606.4 |
FARSA
|
phenylalanyl-tRNA synthetase, alpha subunit |
| chr1_-_85870177 | 2.56 |
ENST00000542148.1
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr4_-_177190364 | 2.54 |
ENST00000296525.3
|
ASB5
|
ankyrin repeat and SOCS box containing 5 |
| chr1_-_160254913 | 2.54 |
ENST00000440949.3
ENST00000368072.5 ENST00000608310.1 ENST00000556710.1 |
PEX19
DCAF8
DCAF8
|
peroxisomal biogenesis factor 19 DDB1 and CUL4 associated factor 8 DDB1- and CUL4-associated factor 8 |
| chr14_-_23504337 | 2.53 |
ENST00000361611.6
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5 |
| chr17_-_42767092 | 2.53 |
ENST00000588687.1
|
CCDC43
|
coiled-coil domain containing 43 |
| chr14_-_23504432 | 2.52 |
ENST00000425762.2
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5 |
| chr14_-_23504087 | 2.51 |
ENST00000493471.2
ENST00000460922.2 |
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5 |
| chr2_+_170366203 | 2.40 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
| chr20_-_32031680 | 2.39 |
ENST00000217381.2
|
SNTA1
|
syntrophin, alpha 1 |
| chr3_-_24207039 | 2.39 |
ENST00000280696.5
|
THRB
|
thyroid hormone receptor, beta |
| chr3_-_23958506 | 2.38 |
ENST00000425478.2
|
NKIRAS1
|
NFKB inhibitor interacting Ras-like 1 |
| chr17_+_40610862 | 2.38 |
ENST00000393829.2
ENST00000546249.1 ENST00000537728.1 ENST00000264649.6 ENST00000585525.1 ENST00000343619.4 ENST00000544137.1 ENST00000589727.1 ENST00000587824.1 |
ATP6V0A1
|
ATPase, H+ transporting, lysosomal V0 subunit a1 |
| chr14_-_74551172 | 2.31 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr12_+_81101277 | 2.30 |
ENST00000228641.3
|
MYF6
|
myogenic factor 6 (herculin) |
| chr17_-_17399701 | 2.28 |
ENST00000225688.3
ENST00000579152.1 |
RASD1
|
RAS, dexamethasone-induced 1 |
| chr8_-_75233563 | 2.27 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr3_-_23958402 | 2.26 |
ENST00000415901.2
ENST00000416026.2 ENST00000412028.1 ENST00000388759.3 ENST00000437230.1 |
NKIRAS1
|
NFKB inhibitor interacting Ras-like 1 |
| chr3_+_12838161 | 2.26 |
ENST00000456430.2
|
CAND2
|
cullin-associated and neddylation-dissociated 2 (putative) |
| chr15_+_36871983 | 2.22 |
ENST00000437989.2
ENST00000569302.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
| chr18_+_11851383 | 2.20 |
ENST00000526991.2
|
CHMP1B
|
charged multivesicular body protein 1B |
| chr11_-_111782696 | 2.17 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
| chr2_-_152589670 | 2.17 |
ENST00000604864.1
ENST00000603639.1 |
NEB
|
nebulin |
| chr1_+_224301787 | 2.15 |
ENST00000366862.5
ENST00000424254.2 |
FBXO28
|
F-box protein 28 |
| chr11_-_111782484 | 2.11 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
| chr20_+_33589048 | 2.09 |
ENST00000446156.1
ENST00000453028.1 ENST00000435272.1 ENST00000433934.2 ENST00000456649.1 |
MYH7B
|
myosin, heavy chain 7B, cardiac muscle, beta |
| chr10_+_123951957 | 2.08 |
ENST00000514539.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr16_-_46797149 | 2.06 |
ENST00000536476.1
|
MYLK3
|
myosin light chain kinase 3 |
| chr12_-_57119300 | 2.03 |
ENST00000546917.1
ENST00000454682.1 |
NACA
|
nascent polypeptide-associated complex alpha subunit |
| chr22_-_36018569 | 2.03 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr14_-_23876801 | 2.02 |
ENST00000356287.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
| chr5_+_71616188 | 2.01 |
ENST00000380639.5
ENST00000543322.1 ENST00000503868.1 ENST00000510676.2 ENST00000536805.1 |
PTCD2
|
pentatricopeptide repeat domain 2 |
| chr10_-_75401500 | 1.98 |
ENST00000359322.4
|
MYOZ1
|
myozenin 1 |
| chr1_-_203055129 | 1.97 |
ENST00000241651.4
|
MYOG
|
myogenin (myogenic factor 4) |
| chr15_+_36871806 | 1.96 |
ENST00000566621.1
ENST00000564586.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
| chr14_-_35183755 | 1.95 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
| chr19_-_51869592 | 1.94 |
ENST00000596253.1
ENST00000309244.4 |
ETFB
|
electron-transfer-flavoprotein, beta polypeptide |
| chr3_-_149688971 | 1.92 |
ENST00000498307.1
ENST00000489155.1 |
PFN2
|
profilin 2 |
| chr18_-_74728998 | 1.92 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
| chr4_-_8073705 | 1.91 |
ENST00000514025.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr9_-_123342415 | 1.91 |
ENST00000349780.4
ENST00000360190.4 ENST00000360822.3 ENST00000359309.3 |
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2 |
| chr6_-_43655511 | 1.90 |
ENST00000372133.3
ENST00000372116.1 ENST00000427312.1 |
MRPS18A
|
mitochondrial ribosomal protein S18A |
| chr22_-_36902522 | 1.89 |
ENST00000397223.4
|
FOXRED2
|
FAD-dependent oxidoreductase domain containing 2 |
| chr9_-_35563896 | 1.86 |
ENST00000399742.2
|
FAM166B
|
family with sequence similarity 166, member B |
| chr19_+_18043810 | 1.85 |
ENST00000445755.2
|
CCDC124
|
coiled-coil domain containing 124 |
| chr12_-_49393092 | 1.85 |
ENST00000421952.2
|
DDN
|
dendrin |
| chr19_+_17326141 | 1.84 |
ENST00000445667.2
ENST00000263897.5 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
| chr8_-_144512576 | 1.84 |
ENST00000333480.2
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
| chr3_+_149689066 | 1.83 |
ENST00000593416.1
|
AC117395.1
|
LOC646903 protein; Uncharacterized protein |
| chr15_-_89010607 | 1.81 |
ENST00000312475.4
|
MRPL46
|
mitochondrial ribosomal protein L46 |
| chr16_+_30387141 | 1.79 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr3_-_69171739 | 1.78 |
ENST00000489031.1
|
LMOD3
|
leiomodin 3 (fetal) |
| chr1_-_156571254 | 1.78 |
ENST00000438976.2
ENST00000334588.7 ENST00000368232.4 ENST00000415314.2 |
GPATCH4
|
G patch domain containing 4 |
| chr17_-_27949911 | 1.78 |
ENST00000492276.2
ENST00000345068.5 ENST00000584602.1 |
CORO6
|
coronin 6 |
| chr5_-_58335281 | 1.77 |
ENST00000358923.6
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr17_-_42767115 | 1.77 |
ENST00000315286.8
ENST00000588210.1 ENST00000457422.2 |
CCDC43
|
coiled-coil domain containing 43 |
| chr17_+_65040678 | 1.76 |
ENST00000226021.3
|
CACNG1
|
calcium channel, voltage-dependent, gamma subunit 1 |
| chr6_-_76072719 | 1.76 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
| chr5_-_71616043 | 1.76 |
ENST00000508863.2
ENST00000522095.1 ENST00000513900.1 ENST00000515404.1 ENST00000457646.4 ENST00000261413.5 |
MRPS27
|
mitochondrial ribosomal protein S27 |
| chr19_+_17326521 | 1.76 |
ENST00000593597.1
|
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
| chr19_-_8386238 | 1.75 |
ENST00000301457.2
|
NDUFA7
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
| chr12_+_56075330 | 1.75 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
| chr3_-_48647470 | 1.74 |
ENST00000203407.5
|
UQCRC1
|
ubiquinol-cytochrome c reductase core protein I |
| chrX_-_153059958 | 1.74 |
ENST00000370092.3
ENST00000217901.5 |
IDH3G
|
isocitrate dehydrogenase 3 (NAD+) gamma |
| chr2_-_242254595 | 1.73 |
ENST00000441124.1
ENST00000391976.2 |
HDLBP
|
high density lipoprotein binding protein |
| chr5_+_71403061 | 1.71 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
| chr14_-_35183886 | 1.69 |
ENST00000298159.6
|
CFL2
|
cofilin 2 (muscle) |
| chr19_+_1383890 | 1.68 |
ENST00000539480.1
ENST00000313408.7 ENST00000414651.2 |
NDUFS7
|
NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) |
| chr17_+_28443819 | 1.67 |
ENST00000479218.2
|
NSRP1
|
nuclear speckle splicing regulatory protein 1 |
| chr22_+_39916558 | 1.66 |
ENST00000337304.2
ENST00000396680.1 |
ATF4
|
activating transcription factor 4 |
| chr14_+_69726656 | 1.65 |
ENST00000337827.4
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
| chr6_+_30585486 | 1.65 |
ENST00000259873.4
ENST00000506373.2 |
MRPS18B
|
mitochondrial ribosomal protein S18B |
| chr8_+_77316233 | 1.64 |
ENST00000603284.1
ENST00000603837.1 |
RP11-706J10.2
RP11-706J10.3
|
RP11-706J10.2 long intergenic non-protein coding RNA 1109 |
| chr11_-_126081532 | 1.64 |
ENST00000533628.1
ENST00000298317.4 ENST00000532674.1 |
RPUSD4
|
RNA pseudouridylate synthase domain containing 4 |
| chr4_-_52904425 | 1.63 |
ENST00000535450.1
|
SGCB
|
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
| chr14_+_77564701 | 1.63 |
ENST00000557115.1
|
KIAA1737
|
CLOCK-interacting pacemaker |
| chr10_+_69869237 | 1.60 |
ENST00000373675.3
|
MYPN
|
myopalladin |
| chr14_-_53417732 | 1.59 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr10_-_123687943 | 1.59 |
ENST00000540606.1
ENST00000455628.1 |
ATE1
|
arginyltransferase 1 |
| chr14_-_53331239 | 1.58 |
ENST00000553663.1
|
FERMT2
|
fermitin family member 2 |
| chr3_+_51989330 | 1.57 |
ENST00000322241.4
|
GPR62
|
G protein-coupled receptor 62 |
| chr3_+_134514093 | 1.57 |
ENST00000398015.3
|
EPHB1
|
EPH receptor B1 |
| chr2_+_28974489 | 1.56 |
ENST00000455580.1
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme |
| chr1_-_226595648 | 1.54 |
ENST00000366790.3
|
PARP1
|
poly (ADP-ribose) polymerase 1 |
| chr2_-_96781984 | 1.53 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
| chr7_-_27219849 | 1.52 |
ENST00000396344.4
|
HOXA10
|
homeobox A10 |
| chr5_+_71403280 | 1.51 |
ENST00000511641.2
|
MAP1B
|
microtubule-associated protein 1B |
| chr19_+_35596873 | 1.51 |
ENST00000313865.6
|
AC020907.1
|
Uncharacterized protein |
| chr1_-_179851611 | 1.50 |
ENST00000610272.1
|
RP11-533E19.7
|
RP11-533E19.7 |
| chrX_-_153059811 | 1.49 |
ENST00000427365.2
ENST00000444450.1 ENST00000370093.1 |
IDH3G
|
isocitrate dehydrogenase 3 (NAD+) gamma |
| chr15_-_83736091 | 1.49 |
ENST00000261721.4
|
BTBD1
|
BTB (POZ) domain containing 1 |
| chr19_-_39322497 | 1.49 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr21_+_47743995 | 1.48 |
ENST00000359568.5
|
PCNT
|
pericentrin |
| chr19_-_41903161 | 1.48 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
| chr16_+_57481382 | 1.48 |
ENST00000564655.1
ENST00000567072.1 ENST00000567933.1 ENST00000563166.1 |
COQ9
|
coenzyme Q9 |
| chr2_+_170683942 | 1.47 |
ENST00000272793.5
|
UBR3
|
ubiquitin protein ligase E3 component n-recognin 3 (putative) |
| chr5_-_16936340 | 1.47 |
ENST00000507288.1
ENST00000513610.1 |
MYO10
|
myosin X |
| chr10_+_99332198 | 1.47 |
ENST00000307518.5
ENST00000298808.5 ENST00000370655.1 |
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr2_+_170683979 | 1.46 |
ENST00000418381.1
|
UBR3
|
ubiquitin protein ligase E3 component n-recognin 3 (putative) |
| chr5_-_41870621 | 1.46 |
ENST00000196371.5
|
OXCT1
|
3-oxoacid CoA transferase 1 |
| chr5_-_149669612 | 1.46 |
ENST00000510347.1
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr1_+_57110972 | 1.46 |
ENST00000371244.4
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
| chrX_+_49126294 | 1.46 |
ENST00000466508.1
ENST00000438316.1 ENST00000055335.6 ENST00000495799.1 |
PPP1R3F
|
protein phosphatase 1, regulatory subunit 3F |
| chr16_+_68877496 | 1.45 |
ENST00000261778.1
|
TANGO6
|
transport and golgi organization 6 homolog (Drosophila) |
| chr1_-_154193091 | 1.45 |
ENST00000362076.4
ENST00000350592.3 ENST00000368516.1 |
C1orf43
|
chromosome 1 open reading frame 43 |
| chr7_-_43909090 | 1.45 |
ENST00000317534.5
|
MRPS24
|
mitochondrial ribosomal protein S24 |
| chr22_-_36013368 | 1.44 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr22_-_50700140 | 1.44 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr22_-_50699701 | 1.43 |
ENST00000395780.1
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr11_+_111782934 | 1.43 |
ENST00000304298.3
|
HSPB2
|
Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA. |
| chr17_+_28443799 | 1.43 |
ENST00000584423.1
ENST00000247026.5 |
NSRP1
|
nuclear speckle splicing regulatory protein 1 |
| chr8_-_145515055 | 1.43 |
ENST00000526552.1
ENST00000529231.1 ENST00000307404.5 |
BOP1
|
block of proliferation 1 |
| chr19_-_3985455 | 1.43 |
ENST00000309311.6
|
EEF2
|
eukaryotic translation elongation factor 2 |
| chr10_-_79397547 | 1.42 |
ENST00000481070.1
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr11_+_66025938 | 1.42 |
ENST00000394066.2
|
KLC2
|
kinesin light chain 2 |
| chr3_-_142720267 | 1.41 |
ENST00000597953.1
|
RP11-91G21.1
|
RP11-91G21.1 |
| chr6_-_135375921 | 1.41 |
ENST00000367820.2
ENST00000314674.3 ENST00000524715.1 ENST00000415177.2 ENST00000367826.2 |
HBS1L
|
HBS1-like (S. cerevisiae) |
| chr8_+_136469684 | 1.41 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
| chr14_+_32964258 | 1.41 |
ENST00000556638.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr12_-_56101647 | 1.40 |
ENST00000347027.6
ENST00000257879.6 ENST00000257880.7 ENST00000394230.2 ENST00000394229.2 |
ITGA7
|
integrin, alpha 7 |
| chr19_-_50316517 | 1.40 |
ENST00000313777.4
ENST00000445575.2 |
FUZ
|
fuzzy planar cell polarity protein |
| chr4_+_83956312 | 1.40 |
ENST00000509317.1
ENST00000503682.1 ENST00000511653.1 |
COPS4
|
COP9 signalosome subunit 4 |
| chr8_+_42911552 | 1.39 |
ENST00000525699.1
ENST00000529687.1 |
FNTA
|
farnesyltransferase, CAAX box, alpha |
| chr1_-_8075693 | 1.38 |
ENST00000467067.1
|
ERRFI1
|
ERBB receptor feedback inhibitor 1 |
| chr14_-_45603657 | 1.38 |
ENST00000396062.3
|
FKBP3
|
FK506 binding protein 3, 25kDa |
| chr2_-_242255060 | 1.37 |
ENST00000413241.1
ENST00000423693.1 ENST00000428482.1 |
HDLBP
|
high density lipoprotein binding protein |
| chr4_+_83956237 | 1.37 |
ENST00000264389.2
|
COPS4
|
COP9 signalosome subunit 4 |
| chr12_-_57630873 | 1.37 |
ENST00000556732.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr1_-_154193009 | 1.36 |
ENST00000368518.1
ENST00000368519.1 ENST00000368521.5 |
C1orf43
|
chromosome 1 open reading frame 43 |
| chr22_-_36236623 | 1.36 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr5_+_173315283 | 1.36 |
ENST00000265085.5
|
CPEB4
|
cytoplasmic polyadenylation element binding protein 4 |
| chr6_-_46889694 | 1.36 |
ENST00000283296.7
ENST00000362015.4 ENST00000456426.2 |
GPR116
|
G protein-coupled receptor 116 |
| chr1_+_100111479 | 1.35 |
ENST00000263174.4
|
PALMD
|
palmdelphin |
| chrX_+_24167828 | 1.35 |
ENST00000379188.3
ENST00000419690.1 ENST00000379177.1 ENST00000304543.5 |
ZFX
|
zinc finger protein, X-linked |
| chr15_-_71146480 | 1.35 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
| chr15_-_83735889 | 1.34 |
ENST00000379403.2
|
BTBD1
|
BTB (POZ) domain containing 1 |
| chr10_-_123687497 | 1.34 |
ENST00000369040.3
ENST00000224652.6 ENST00000369043.3 |
ATE1
|
arginyltransferase 1 |
| chr2_-_127864839 | 1.34 |
ENST00000409400.1
ENST00000357970.3 ENST00000393040.3 ENST00000348750.4 ENST00000259238.4 ENST00000346226.3 ENST00000393041.3 ENST00000351659.3 ENST00000352848.3 ENST00000316724.5 |
BIN1
|
bridging integrator 1 |
| chr7_-_42971759 | 1.34 |
ENST00000538645.1
ENST00000445517.1 ENST00000223321.4 |
PSMA2
|
proteasome (prosome, macropain) subunit, alpha type, 2 |
| chr9_+_95997205 | 1.34 |
ENST00000411624.1
|
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr10_+_99332529 | 1.33 |
ENST00000455090.1
|
ANKRD2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
| chr11_-_18270182 | 1.33 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
| chr9_+_72002837 | 1.33 |
ENST00000377216.3
|
FAM189A2
|
family with sequence similarity 189, member A2 |
| chr1_+_164528866 | 1.33 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr18_+_29078131 | 1.32 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr10_-_123687431 | 1.32 |
ENST00000423243.1
|
ATE1
|
arginyltransferase 1 |
| chr3_-_67705006 | 1.31 |
ENST00000492795.1
ENST00000493112.1 ENST00000307227.5 |
SUCLG2
|
succinate-CoA ligase, GDP-forming, beta subunit |
| chr19_-_50316489 | 1.30 |
ENST00000533418.1
|
FUZ
|
fuzzy planar cell polarity protein |
| chr1_-_201438282 | 1.30 |
ENST00000367311.3
ENST00000367309.1 |
PHLDA3
|
pleckstrin homology-like domain, family A, member 3 |
| chr1_+_179851893 | 1.30 |
ENST00000531630.2
|
TOR1AIP1
|
torsin A interacting protein 1 |
| chr17_+_61904766 | 1.30 |
ENST00000581842.1
ENST00000582130.1 ENST00000584320.1 ENST00000585123.1 ENST00000580864.1 |
PSMC5
|
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
| chr7_-_27239703 | 1.29 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
| chr19_+_38865398 | 1.29 |
ENST00000585598.1
ENST00000602911.1 ENST00000592561.1 |
PSMD8
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
| chr10_-_79397391 | 1.28 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr11_+_109964087 | 1.27 |
ENST00000278590.3
|
ZC3H12C
|
zinc finger CCCH-type containing 12C |
| chr1_+_179851999 | 1.27 |
ENST00000527391.1
|
TOR1AIP1
|
torsin A interacting protein 1 |
| chr10_-_123687399 | 1.27 |
ENST00000543447.1
|
ATE1
|
arginyltransferase 1 |
| chr17_-_9694614 | 1.27 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
| chr14_+_77564440 | 1.27 |
ENST00000361786.2
ENST00000555437.1 ENST00000555611.1 ENST00000554658.1 |
KIAA1737
|
CLOCK-interacting pacemaker |
| chr22_-_50699972 | 1.27 |
ENST00000395778.3
|
MAPK12
|
mitogen-activated protein kinase 12 |
| chr1_-_113162040 | 1.26 |
ENST00000358039.4
ENST00000369668.2 |
ST7L
|
suppression of tumorigenicity 7 like |
| chr1_+_100111580 | 1.26 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
| chr1_+_202995611 | 1.26 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
| chr8_+_55370487 | 1.26 |
ENST00000297316.4
|
SOX17
|
SRY (sex determining region Y)-box 17 |
| chr1_+_17906970 | 1.26 |
ENST00000375415.1
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like |
| chr19_+_13056663 | 1.26 |
ENST00000541222.1
ENST00000316856.3 ENST00000586534.1 ENST00000592268.1 |
RAD23A
|
RAD23 homolog A (S. cerevisiae) |
| chrX_+_119005399 | 1.25 |
ENST00000371437.4
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
| chr1_+_64058939 | 1.25 |
ENST00000371084.3
|
PGM1
|
phosphoglucomutase 1 |
| chr2_+_210517895 | 1.24 |
ENST00000447185.1
|
MAP2
|
microtubule-associated protein 2 |
| chrX_+_135579238 | 1.24 |
ENST00000535601.1
ENST00000448450.1 ENST00000425695.1 |
HTATSF1
|
HIV-1 Tat specific factor 1 |
| chr7_+_72848092 | 1.24 |
ENST00000344575.3
|
FZD9
|
frizzled family receptor 9 |
| chr17_-_4843206 | 1.23 |
ENST00000576951.1
|
SLC25A11
|
solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 |
| chr9_+_70971815 | 1.23 |
ENST00000396392.1
ENST00000396396.1 |
PGM5
|
phosphoglucomutase 5 |
| chr16_+_57481349 | 1.23 |
ENST00000262507.6
ENST00000565964.1 |
COQ9
|
coenzyme Q9 |
| chr9_+_95947198 | 1.23 |
ENST00000448039.1
ENST00000297954.4 ENST00000395477.2 ENST00000395475.2 ENST00000349097.3 ENST00000427277.2 ENST00000356055.3 ENST00000432730.1 |
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr19_-_50316423 | 1.23 |
ENST00000528094.1
ENST00000526575.1 |
FUZ
|
fuzzy planar cell polarity protein |
| chr7_+_139025875 | 1.23 |
ENST00000297534.6
|
C7orf55
|
chromosome 7 open reading frame 55 |
| chr1_+_202317855 | 1.23 |
ENST00000356764.2
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
Network of associatons between targets according to the STRING database.
First level regulatory network of YY1_YY2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 5.5 | GO:0016598 | protein arginylation(GO:0016598) |
| 1.4 | 4.1 | GO:1902309 | regulation of heart rate by hormone(GO:0003064) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.0 | 3.9 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.9 | 3.5 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.9 | 3.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.8 | 12.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.7 | 5.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.7 | 5.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.7 | 2.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.7 | 0.7 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.7 | 2.6 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 | 1.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.6 | 2.5 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.6 | 4.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.6 | 2.9 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.5 | 6.3 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.5 | 5.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.5 | 1.6 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.5 | 1.0 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.5 | 2.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.5 | 3.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.5 | 1.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.5 | 2.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 1.3 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.4 | 1.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.4 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 3.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.4 | 1.3 | GO:0070446 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.4 | 2.2 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.4 | 2.2 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 | 5.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.4 | 1.3 | GO:0061010 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) gall bladder development(GO:0061010) |
| 0.4 | 0.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.4 | 1.2 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.4 | 2.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 | 3.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 3.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.4 | 1.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 | 1.5 | GO:0061743 | motor learning(GO:0061743) |
| 0.4 | 1.5 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 | 1.1 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.4 | 1.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 1.9 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 0.4 | 0.4 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.4 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.4 | 1.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 | 2.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.4 | 5.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 | 1.1 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.4 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.4 | 2.8 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 1.4 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.3 | 5.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 | 6.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.3 | 1.4 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.3 | 7.7 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 | 1.7 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.3 | 1.0 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.3 | 2.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 6.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 1.0 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.3 | 1.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.3 | 0.3 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 | 1.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 | 0.9 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 | 0.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.3 | 0.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.3 | 1.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 1.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.3 | 1.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.3 | 5.9 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.3 | 0.9 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.3 | 3.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.3 | 0.9 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.3 | 0.9 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.3 | 1.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.3 | 0.9 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.3 | 0.9 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 | 2.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 1.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.3 | 0.8 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.1 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.3 | 0.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.3 | 2.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.3 | 1.9 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.3 | 1.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.3 | 1.3 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.3 | 0.8 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.3 | 0.8 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 0.5 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.3 | 1.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.3 | 0.5 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 0.8 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.3 | 18.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 | 2.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 | 1.2 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.2 | 1.0 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 | 0.5 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
| 0.2 | 1.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 3.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.2 | 0.7 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 | 2.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 2.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.2 | 0.9 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 2.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 2.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 2.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 | 1.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.2 | 1.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 3.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 0.8 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.2 | 1.9 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.2 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 2.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 1.9 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.6 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 | 9.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 24.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 1.8 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 3.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 0.6 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 | 3.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 2.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 | 4.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 5.9 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.2 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.2 | 3.3 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.2 | 1.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 1.0 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.2 | 0.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.2 | 0.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 2.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.6 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.2 | 0.6 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.2 | 0.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 4.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 0.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 0.5 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
| 0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 2.5 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.2 | 1.8 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.2 | 4.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 0.5 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 1.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 | 1.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 | 1.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 1.8 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 0.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.2 | 2.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.2 | 1.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 1.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 1.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 1.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 1.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 0.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 | 1.5 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.2 | 0.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.2 | 0.5 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.2 | 1.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 0.2 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.2 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 2.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.1 | 2.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.1 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.1 | 3.6 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 0.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.1 | 1.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 0.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.1 | 4.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 0.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 1.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 1.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.0 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.8 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 | 0.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.1 | 2.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 | 0.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 | 2.5 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 0.9 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.1 | 1.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
| 0.1 | 2.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.1 | 2.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 1.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.7 | GO:0071046 | nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.1 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.1 | 3.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.1 | 1.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 1.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 2.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 1.5 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 | 2.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 1.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.4 | GO:0006816 | calcium ion transport(GO:0006816) |
| 0.1 | 0.5 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 2.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 4.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 3.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 13.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.5 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 | 0.5 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.1 | 0.8 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.1 | 0.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 | 0.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 | 2.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 1.0 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 | 1.0 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 1.6 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 1.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 1.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 0.7 | GO:0032445 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 1.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 1.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 | 0.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 0.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.1 | 2.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 1.5 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.8 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 0.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 | 1.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.5 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.1 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 | 1.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.1 | 1.5 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
| 0.1 | 1.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 | 25.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 2.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.3 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 0.7 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 0.1 | 4.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 4.4 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 | 1.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.1 | 1.4 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.1 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 | 1.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.3 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 2.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 | 0.7 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.1 | 0.7 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.6 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.3 | GO:0002762 | negative regulation of myeloid leukocyte differentiation(GO:0002762) negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 3.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 0.4 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) dorsal root ganglion development(GO:1990791) |
| 0.1 | 0.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 2.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 | 0.9 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 4.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.2 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.5 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 2.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.4 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
| 0.1 | 0.5 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 2.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.1 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) vitamin D catabolic process(GO:0042369) |
| 0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 | 2.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 1.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.1 | 1.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 1.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 1.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.2 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.1 | 1.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.5 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 1.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.4 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.8 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 2.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.2 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 1.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 | 0.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.1 | 1.5 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 1.9 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.1 | 0.4 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.1 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 1.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 2.1 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.1 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.2 | GO:0014040 | acetaldehyde metabolic process(GO:0006117) positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.1 | 3.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 1.8 | GO:0007517 | muscle organ development(GO:0007517) |
| 0.1 | 0.2 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 | 0.5 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 | 0.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 3.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 2.3 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.1 | 0.7 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.3 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.1 | 0.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 0.5 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 4.8 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.1 | 0.6 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 0.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.1 | 0.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 | 0.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.6 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 | 0.3 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.1 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.8 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) RNA repair(GO:0042245) |
| 0.0 | 0.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 | 0.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.0 | 1.4 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.0 | 0.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.0 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.0 | 0.9 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.0 | 0.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.0 | 3.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 1.5 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 | 0.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.0 | 0.1 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 0.0 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
| 0.0 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.0 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.0 | 1.1 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.0 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.0 | 0.3 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 | 1.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 1.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.0 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 2.0 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.0 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.0 | 0.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.0 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.0 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 | 0.8 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 1.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.0 | 0.3 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 1.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.1 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
| 0.0 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 3.4 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.0 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 1.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.0 | 0.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.0 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.0 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.0 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.0 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 3.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 1.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.0 | 0.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.0 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 0.4 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 0.2 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.4 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.1 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.3 | GO:0007031 | peroxisome organization(GO:0007031) |
| 0.0 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.0 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 | 1.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.2 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.0 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.0 | 2.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.0 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 1.1 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 | 0.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
| 0.0 | 0.4 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.0 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.0 | 0.3 | GO:0097369 | sodium ion import(GO:0097369) |
| 0.0 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.0 | 0.1 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 | 0.3 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 0.9 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 | 0.8 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 | 0.1 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 | 0.3 | GO:0021697 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar cortex formation(GO:0021697) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 0.8 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 | 1.0 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.0 | 0.0 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 1.2 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.0 | 0.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.0 | 0.2 | GO:0043518 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.0 | 0.1 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) regulation of rubidium ion transmembrane transporter activity(GO:2000686) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.3 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.0 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.0 | 1.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.1 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.0 | 0.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.6 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
| 0.0 | 0.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 | 1.2 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.2 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
| 0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 0.3 | GO:0042148 | strand invasion(GO:0042148) |
| 0.0 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.6 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.0 | 0.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 1.0 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.0 | 1.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.0 | 0.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
| 0.0 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 1.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.7 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 1.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 0.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.0 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 1.9 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.8 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.8 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.4 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.0 | 0.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.0 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.0 | 0.5 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 0.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 | 0.1 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.0 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.0 | 2.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.0 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 | 0.2 | GO:0009116 | nucleoside metabolic process(GO:0009116) |
| 0.0 | 0.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 2.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.5 | 2.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.5 | 8.8 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.5 | 4.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.5 | 4.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 1.8 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.5 | 3.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.4 | 3.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.4 | 5.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.4 | 1.7 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.4 | 4.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.4 | 3.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 7.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.4 | 2.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 1.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.4 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.4 | 6.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 1.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.3 | 2.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.3 | 11.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.3 | 3.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.3 | 5.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 3.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.3 | 1.2 | GO:1990745 | EARP complex(GO:1990745) |
| 0.3 | 1.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.3 | 5.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.3 | 1.7 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.3 | 1.6 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.3 | 3.7 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 0.7 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.2 | 3.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 2.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 3.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.2 | 1.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 2.3 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 0.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.2 | 0.8 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.2 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.2 | 5.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.2 | 2.4 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 13.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 0.8 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.2 | 5.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 2.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 1.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.2 | 2.8 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 0.5 | GO:0034686 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
| 0.2 | 2.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 5.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 1.0 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 4.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 0.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.2 | 1.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.2 | 1.3 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 1.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.2 | 1.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.2 | 1.5 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.2 | 1.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 5.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 0.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 2.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 18.4 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.1 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 2.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 2.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 2.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 1.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 0.5 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.1 | 1.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 5.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.1 | 0.7 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 8.8 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 5.8 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 3.8 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 2.5 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.0 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) DNA-directed RNA polymerase II, holoenzyme(GO:0016591) RNA polymerase complex(GO:0030880) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
| 0.1 | 0.3 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.1 | 3.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 1.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 6.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 5.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 2.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 1.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 4.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.3 | GO:0030849 | autosome(GO:0030849) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 4.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.3 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 1.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 3.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 1.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 1.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 9.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 1.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 1.9 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 2.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 13.3 | GO:0031674 | I band(GO:0031674) |
| 0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 1.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 2.1 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 0.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.4 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 3.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 8.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.4 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 6.8 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.3 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.1 | 1.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.1 | 0.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 0.7 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 1.6 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.1 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 4.6 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 1.1 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.0 | 0.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.0 | 24.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) nuclear lamina(GO:0005652) |
| 0.0 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
| 0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.0 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.0 | 1.5 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.0 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.2 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 2.6 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 0.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
| 0.0 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.0 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.7 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 3.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 3.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.4 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.0 | 4.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 1.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 1.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.4 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.0 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 4.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 0.2 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 1.3 | GO:0030016 | myofibril(GO:0030016) |
| 0.0 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 1.1 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 40.4 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 0.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 0.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.0 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 2.1 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
| 0.0 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.1 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.0 | 1.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.2 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
| 0.0 | 0.2 | GO:0044456 | synapse part(GO:0044456) postsynapse(GO:0098794) |
| 0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 2.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.3 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 1.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 1.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 3.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.6 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.0 | 0.6 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.4 | 5.5 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 1.1 | 3.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.9 | 3.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.9 | 3.5 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.9 | 2.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.8 | 2.3 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.7 | 3.7 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.7 | 2.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.7 | 2.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.6 | 1.9 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.6 | 2.5 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.6 | 4.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.6 | 4.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.6 | 5.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.6 | 2.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.6 | 1.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.5 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.5 | 2.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.5 | 3.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.5 | 1.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.5 | 1.4 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.5 | 1.8 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.4 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.4 | 2.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.4 | 1.3 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.4 | 2.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.4 | 1.2 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.4 | 1.2 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.4 | 1.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.4 | 1.1 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.4 | 1.1 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.4 | 1.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.4 | 2.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 1.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 1.7 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 2.0 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.3 | 1.6 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.3 | 1.0 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.3 | 1.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.3 | 0.9 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.3 | 2.5 | GO:0042835 | BRE binding(GO:0042835) |
| 0.3 | 1.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 1.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.3 | 0.8 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.3 | 17.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 8.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.3 | 1.9 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 0.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 0.8 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 3.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 1.0 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 0.7 | GO:0000166 | nucleotide binding(GO:0000166) nucleoside phosphate binding(GO:1901265) |
| 0.2 | 1.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 1.0 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.2 | 1.0 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.2 | 2.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 3.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.2 | 0.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 2.9 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.2 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 7.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 1.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 0.6 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.2 | 13.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 0.6 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.2 | 5.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.2 | 1.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 4.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 5.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.2 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.2 | 0.6 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.2 | 1.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 0.7 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.2 | 2.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.2 | 1.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 2.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 0.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.2 | 0.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.2 | 1.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 0.8 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.2 | 0.5 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.2 | 2.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 2.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.2 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 1.3 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 5.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 1.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 5.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.1 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 6.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 1.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 16.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 2.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.1 | 0.5 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.1 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 2.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 1.8 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 1.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 5.9 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.1 | 1.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 2.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 0.5 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.1 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 3.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 3.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 0.4 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.1 | 0.8 | GO:0051998 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.1 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.5 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 1.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 5.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.1 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.6 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 1.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.4 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 2.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 1.0 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.7 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 0.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 2.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.1 | 3.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 1.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.7 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.1 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 1.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.5 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.1 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.1 | 0.7 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.1 | 1.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 1.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 1.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 2.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.1 | 3.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.9 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 0.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 1.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 19.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 1.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.3 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.1 | 0.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 2.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 4.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 0.7 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.1 | 0.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.1 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.1 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 3.0 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.1 | 1.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.3 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 3.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 1.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 5.1 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.1 | 0.5 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 5.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.1 | 0.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 1.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 2.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.3 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.1 | 1.4 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 1.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 0.3 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.1 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 3.7 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.0 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.0 | 0.1 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.0 | 0.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.0 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 2.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 1.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 1.7 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.0 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 4.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.0 | 0.2 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.0 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.5 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.4 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.0 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 2.3 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.2 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.0 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.0 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 1.2 | GO:0004383 | adenylate cyclase activity(GO:0004016) guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.0 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.0 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 2.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.0 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 2.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 1.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.1 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.0 | 0.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.0 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.0 | 0.4 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 1.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 2.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.0 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.0 | 0.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.0 | 1.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.0 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 7.7 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 1.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 5.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 1.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 1.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.0 | 0.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 4.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 1.3 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 0.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 1.7 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 0.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.0 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.0 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 11.9 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 2.4 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.0 | 1.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 1.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.0 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.0 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 1.5 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 1.8 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 1.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 7.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 8.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 8.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.2 | 12.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 3.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 2.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 2.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 1.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 7.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 2.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 4.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 1.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 2.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 1.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 1.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 2.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 3.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 4.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.0 | 1.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.0 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.0 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 2.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 1.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 6.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 10.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.3 | 6.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.3 | 6.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 7.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 22.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 16.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.2 | 6.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 13.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 4.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 4.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 11.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 1.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 4.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 5.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 3.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 6.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 2.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 8.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 5.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 1.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 21.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 1.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 2.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 2.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 1.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 5.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 2.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 3.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 2.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 1.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 0.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 2.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 3.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.1 | 1.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 5.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 6.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 1.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 2.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 1.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 2.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.0 | 1.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.0 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 1.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 1.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 3.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 2.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.0 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 1.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 4.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 1.9 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.0 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |